Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease

We identified serum CCL17 as a clinically measurable biomarker for predicting non-IPF-ILD progression. Serum CCL17 could enable the stratification of patients at risk of non-IPF-ILD progression, leading to appropriate early therapeutic intervention.

Authors

Institutions

Publication Details

Journal
Respiratory Research
Published
2025-04-23
DOI
https://doi.org/10.1186/s12931-025-03237-2
Citations
1
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease

Yoshikazu Inoue, Yuko Abe, Mari Tone, Atsushi Kumanogoh et al.
1 citations
Respiratory Research
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
1.52
article

Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung disease

Yoshikazu Inoue, Yuko Abe, Mari Tone, Atsushi Kumanogoh, Yujiro Naito, Takayuki Niitsu, Shohei Koyama, Takehiro Hasegawa, Kentaro Masuhiro, Kota Iwahori, Izumi Nagatomo, Shigeyuki Shichino, Kiyoharu Fukushima, Satoshi Nojima, Moritz Pohl, Yuichi Adachi, Ryuya Edahiro, Hanako Yoshimura, Takatoshi Enomoto, Yoshito Takeda, Reina Hara, Satoshi Tanizaki, Daisuke Nakatsubo, Saori Amiya, Yoshimi Noda, Mana Nakayama, Maiko Naito, Kotaro Miyake, Masahiro Yanagawa, Makoto Yamamoto, Hanna B. Lunding, Yuya Shirai, Haruhiko Hirata, Takayuki Shiroyama, Feng Zhao, Takahiro Kawasaki
article en
1 citations

Abstract

We identified serum CCL17 as a clinically measurable biomarker for predicting non-IPF-ILD progression. Serum CCL17 could enable the stratification of patients at risk of non-IPF-ILD progression, leading to appropriate early therapeutic intervention.

Respiratory ResearchVol. 26(1)
Tokyo University of Science (JP), Sysmex (Germany) (DE), RIKEN Center for Integrative Medical Sciences (JP), Fukujuji Hospital (JP), NHO Kinki Chuo Chest Medical Center (JP), Osaka International University (JP), Sysmex (Japan) (JP), The University of Osaka (JP)
Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 19%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.